Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 857Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsNuclear Structure and Function

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 4 of the 6 sources its claims cite were checked for support.

Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice

Open access
Jaskelioff, Mariela, Muller, Florian L., Paik, Ji-Hye, Thomas, Emily, Jiang, Shan, Adams, Andrew C., Sahin, Ergun, Kost-Alimova, Maria, Protopopov, Alexei, Cadiñanos, Juan, Horner, James W., Maratos-Flier, Eleftheria, DePinho, Ronald A.·2011·Nature

Abstract

An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo. Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses. Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons, this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.

Overview

CoChat Summary

## TL;DR

In aged telomerase-deficient TERT-ER mice, a 4-week course of 4-OHT-induced telomerase reactivation reversed multiple degenerative phenotypes rather than merely halting them. The treatment restored telomere signal and reduced DNA damage responses, with functional recovery in testes, spleen, intestine, brain myelination, and innate olfactory behavior.

## Key findings

  • G4 TERT-ER mice phenocopied late-generation telomerase-deficient mice and had reduced survival: median survival was 43.5 vs. 86.8 weeks for telomere-intact mice.
  • After 4 weeks of 4-OHT, telomerase reactivation increased telomere-FISH signal, reduced p53 activation, reduced p21 expression, and decreased 53BP1 foci in splenocytes and intestinal crypt cells.
  • Telomerase reactivation reversed tissue degeneration, including restoration of normal testes and spleen size, reduced apoptosis in testes germ cells and intestinal crypt cells, and increased fecundity.
  • In the brain, treatment restored Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocytes; brain weight improved from 77.3 ± 3.3% to 89.7 ± 4.0% of G0 levels, and the myelin g-ratio shifted from 0.7756 ± 0.0054 in G4 mice toward 0.7058 ± 0.0006 after treatment.
  • Innate olfactory avoidance recovered: untreated G4 mice failed to avoid lower 2-MB concentrations, but after 4-OHT they showed avoidance at all tested concentrations (1.87 × 10^-4 M to 1.87 × 10^-6 M).

## Methods

  • The authors generated a knock-in TERT-ER mouse with a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-estrogen receptor fusion under the endogenous TERT promoter; studies used adult male mice, typically 30–35 weeks old, across successive generations (G0 to G4).
  • They assessed telomerase activity, telomere status, DNA damage markers, histology, neurosphere self-renewal and differentiation, myelination, and olfactory behavior using TRAP assays, IHC/FISH, cell culture, electron microscopy, and behavioral testing.
  • Statistical analysis used one-way ANOVA with Bonferroni post test and Mantel-Cox tests for survival curves.

## Limitations

  • The paper states that carcinogenesis was not observed after the brief telomerase reactivation course, but also notes this was “data not shown” and that longer or later-life reactivation may provoke carcinogenesis.
  • The study was performed on adult males only, so the text makes evident a sex limitation.
  • The olfactory test sample sizes were small in the methods (n=4 per experimental condition), which is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/nature09603

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

3 Valid · 0 Not valid · 1 Not checked · 19 Own results and interpretations

13 more claims

Create a free account to see all 23 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 2
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

13 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 36 references

Cited by

See all 857

Metadata

Authors
Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., Horner, J. W., Maratos-Flier, E., & DePinho, R. A.
Affiliations
  • Harvard University (US)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
DePinho, Ronald A.
Venue
Nature
Published
2010-11-28
Volume
469
Issue
7328
Pages
102-106
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2053352181
Cited by
857
References
36
Citations by year
2026: 33 · 2025: 42 · 2024: 43 · 2023: 45 · 2022: 43 · 2021: 80 · 2020: 45 · 2019: 54 · 2018: 45 · 2017: 60 · 2016: 55 · 2015: 49 · 2014: 62 · 2013: 70 · 2012: 67
FWCI
43.28
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
National Cancer Institute (U01CA141508, R01CA084628)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
telomerase reactivation, telomere elongation, telomere dysfunction, aging, tissue degeneration, DNA damage signaling, regenerative therapy, stem cell depletion, cellular senescence, carcinogenesis risk
MeSH terms
Doublecortin Protein, Aging, Animals, Avoidance Learning, Brain, Cell Differentiation, Cells, Cultured, DNA Damage, Enzyme Activation, Enzyme Reactivators, Mice, Inbred C57BL, Myelin Sheath, Organ Size, Phenotype, Receptors, Estrogen, Recombinant Fusion Proteins, Smell, Tamoxifen, Telomere, Telomerase, Models, Animal, Regenerative Medicine, Cell Proliferation, Mice, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. https://app.cochat.ai/papers/10.1038/nature09603
The paper
Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., Horner, J. W., Maratos-Flier, E., & DePinho, R. A. (2011). Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. https://doi.org/10.1038/nature09603

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.